|
⚲
|
| Keyboard |
| Patel Samir Rashmikant
✚
|
|
|---|---|
| CIK # | 0001702447 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001702447] | |
| 4 | [0001702447] | |
| SC 13D | [0001702447] | |
| SC 13G | [0001702447] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Patel Samir Rashmikant | Tuhura Biosciences Inc/NV | [2024-10-25] |
| Patel Samir Rashmikant | Akari Therapeutics PLC | [2024-06-07] |
| Patel Samir Rashmikant | Akari Therapeutics PLC | [2019-10-04] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Morria Biopharmaceuticals PLC | |
| Patel Samir Rashmikant | |
| CytoDyn Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 231,997 | $0.40 | 92,799 |
|
Morria Biopharmaceuticals PLC AKTX
Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 231,997 | ||
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 618,658 | $0.40 | 247,463 |
|
Morria Biopharmaceuticals PLC AKTX
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
|
2025-12-16 | Buy | 618,658 | ||
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 175,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 225,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Series A Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 406,250 | $1.12 | 455,000 |
|
Morria Biopharmaceuticals PLC AKTX
American Depositary Shares representing Ordinary Shares
|
2025-03-06 | Grant | 406,250 | $1.12 | 455,000 |
|
Morria Biopharmaceuticals PLC AKTX
Series B Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 406,250 | $1.12 | 455,000 |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 152,672,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2025-01-03 | Grant | 208,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-27 | Grant | 400,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-26 | Grant | 3,200,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-24 | Grant | 7,500,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-23 | Grant | 1,400,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-20 | Grant | 1,400,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-02 | Grant | 419,286,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Warrants (Right to Buy) · derivative
|
2024-12-02 | Grant | 419,286,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2024-11-30 | Grant | 162,604,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-11-14 | Grant | 1,404,622,000 | ||
| showing 20 of 34 most recent transactions | |||||